Singh Ramesh, Pochampally Radhika, Watabe Kounosuke, Lu Zhaohui, Mo Yin-Yuan
Department of Endocrinology, PLA General Hospital, Beijing 100853, PR China.
Mol Cancer. 2014 Nov 26;13:256. doi: 10.1186/1476-4598-13-256.
Exosomes are 30-100 nm membrane vesicles of endocytic origin, mediating diverse biological functions including tumor cell invasion, cell-cell communication and antigen presentation through transfer of proteins, mRNAs and microRNAs. Recent evidence suggests that microRNAs can be released through ceramide-dependent secretory machinery regulated by neutral sphingomyelinase 2 (nSMase2) enzyme encoded by the smpd3 gene that triggers exosome secretion. However, whether exosome-mediated microRNA transfer plays any role in cell invasion remains poorly understood. Thus, the aim of this study was to identify the exosomal microRNAs involved in breast cancer invasion.
The expression level of endogenous and exosomal miRNAs were examined by real time PCR and the expression level of target proteins were detected by western blot. Scanning electron and confocal microscopy were used to characterize exosomes and to study its uptake and transfer. Luciferase reporter plasmids and its mutant were used to confirm direct targeting. Furthermore, the functional significance of exosomal miR-10b was estimated by invasion assay.
In this study, we demonstrate that microRNA carrying exosomes can be transferred among different cell lines through direct uptake. miR-10b is highly expressed in metastatic breast cancer MDA-MB-231 cells as compared to non-metastatic breast cancer cells or non-malignant breast cells; it is actively secreted into medium via exosomes. In particular, nSMase2 or ceramide promotes the exosome-mediated miR-10b secretion whereas ceramide inhibitor suppresses this secretion. Moreover, upon uptake, miR-10b can suppress the protein level of its target genes such as HOXD10 and KLF4, indicating its functional significance. Finally, treatment with exosomes derived from MDA-MB-231 cells could induce the invasion ability of non-malignant HMLE cells.
Together, our results suggest that a set of specific microRNAs may play an important role in modulating tumor microenvironment through exosomes. Thus, a better understanding of this process may aid in the development of novel therapeutic agents.
外泌体是起源于内吞作用的30 - 100纳米膜囊泡,通过蛋白质、信使核糖核酸(mRNA)和微小核糖核酸(miRNA)的传递介导多种生物学功能,包括肿瘤细胞侵袭、细胞间通讯和抗原呈递。最近的证据表明,miRNA可通过由smpd3基因编码的中性鞘磷脂酶2(nSMase2)调控的神经酰胺依赖性分泌机制释放,该酶触发外泌体分泌。然而,外泌体介导的miRNA转移在细胞侵袭中是否发挥作用仍知之甚少。因此,本研究的目的是鉴定参与乳腺癌侵袭的外泌体miRNA。
通过实时聚合酶链反应(PCR)检测内源性和外泌体miRNA的表达水平,通过蛋白质免疫印迹法检测靶蛋白的表达水平。使用扫描电子显微镜和共聚焦显微镜对外泌体进行表征,并研究其摄取和转移。荧光素酶报告质粒及其突变体用于确认直接靶向。此外,通过侵袭试验评估外泌体miR - 10b的功能意义。
在本研究中,我们证明携带miRNA的外泌体可通过直接摄取在不同细胞系之间转移。与非转移性乳腺癌细胞或非恶性乳腺细胞相比,miR - 10b在转移性乳腺癌MDA - MB - 231细胞中高表达;它通过外泌体被主动分泌到培养基中。特别是,nSMase2或神经酰胺促进外泌体介导的miR - 10b分泌,而神经酰胺抑制剂抑制这种分泌。此外,摄取后,miR - 10b可抑制其靶基因如HOXD10和KLF4的蛋白水平,表明其功能意义。最后,用源自MDA - MB - 231细胞的外泌体处理可诱导非恶性HMLE细胞的侵袭能力。
总之,我们的结果表明,一组特定的miRNA可能通过外泌体在调节肿瘤微环境中发挥重要作用。因此,更好地理解这一过程可能有助于开发新型治疗药物。